At what pace is the tissue sectioning market growing, and what is its estimated value?
The tissue sectioning market size has grown rapidly in recent years. It will grow from $0.76 billion in 2024 to $0.83 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, growing aging population, rising investments in life sciences research, expanding biotechnology and pharmaceutical industries, government initiatives supporting research, rising demand for companion diagnostics, increasing awareness about early disease detection, growth in regenerative medicine.
The tissue sectioning market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to demand for personalized medicine, growth in biobanks, investments in research and development, increasing healthcare expenditure, growing awareness about early disease detection, emergence of digital pathology, rising demand for biomarker discovery, growing biopharmaceutical industry, rising demand for point of care testing. Major trends in the forecast period include advancements in automation technology, integration of ai and machine learning, digital pathology integration, adoption of 3d tissue sectioning techniques, development of high throughput solutions, expansion of research applications, development of novel cutting techniques, advancements in imaging modalities, adoption of cryosectioning techniques.
Get Your Free Sample of The Global Tissue Sectioning Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp
What are the top drivers to the rising demand in the tissue sectioning market?
The rising surgical procedures are expected to propel the growth of the tissue sectioning market going forward. Surgical procedures are medical interventions involving instruments to diagnose, treat, or repair the body. The rise in surgical procedures is due to advancements in medical technology, demographic changes, and shifts in healthcare practices. Tissue sectioning aids surgical procedures by providing precise, thin tissue slices for histological analysis, enabling accurate diagnosis, treatment planning, and transplantation. For instance, in December 2023, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency for public health and welfare, in 2022–23, there were 735,500 patients admitted for surgery from public hospital elective surgery waiting lists, marking an 18% rise from 2021–22. Therefore, rising surgical procedures are driving the tissue sectioning market.
How is the tissue sectioning market segmented?
The tissue sectioning market covered in this report is segmented –
1) By Product: Accessories And Consumables, Instruments, Services
2) By Technology: Automatic, Manual, Semi-Automatic
3) By Application: Diagnosis, Research
4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers
Subsegments:
1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips)
2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems
3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training Services
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report
Who are the top competitors in the tissue sectioning market?
Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Labcorp Drug Development, Agilent Technologies Inc., Leica Biosystems Nussloch GmbH, Abcam Limited, Sakura Finetek USA Inc., Ted Pella Inc., Santa Cruz Biotechnology Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., LLS ROWIAK LaserLabSolutions GmbH, SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc.
What significant trends should we anticipate in the tissue sectioning market over the forecast period?
Major companies operating in the tissue sectioning market are developing advanced technologies, such as next-generation spatial gene expression technology, to enhance tissue analysis and diagnostics. Next-generation spatial gene expression technology allows for the detailed mapping of gene activity within tissue sections, providing insights into the spatial organization of gene expression and tissue architecture. For instance, in March 2024, 10x Genomics, a US-based biotechnology company, launched Visium HD, a next-generation spatial gene expression technology that enables precise gene expression mapping in detailed anatomical structures. It is designed to provide high-resolution spatial gene expression data at single-cell scale resolution from formalin-fixed, paraffin-embedded (FFPE) tissue sections. This technology allows for comprehensively characterizing FFPE tissue sections by measuring whole transcriptome spatial gene expression at single-cell resolution.
Which regional trends are influencing the tissue sectioning market, and which area dominates the industry?
North America was the largest region in the tissue sectioning market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Tissue Sectioning Market Report 2025 Offer?
The tissue sectioning market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Tissue sectioning is a crucial technique in histology and pathology to prepare thin tissue slices for microscopic examination. This process is essential for studying the microscopic structure of tissues and understanding the pathological changes associated with diseases.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16555
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
